DAHUA-TECHNOLOGY
22.11.2022 13:46:43 CET | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has been accelerating the innovation and exploration of Full-color Technology. Featuring TiOC, Panoramic, Zoom and 4K, the new generation of Dahua full-color series provides a wide range of low-light solutions that integrate different intelligent technologies to solve pain points in various scenarios, allowing installers and end users to choose the ideal solution that best suits their needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005376/en/
Inadequate availability of light is one of the major challenges of every monitoring system. Images taken under such lighting condition are often not clear, have detail loss, and even contain noise, making it difficult to detect or trace back targets in case of an event. The Dahua Full-color cameras were developed to address these demanding monitoring challenges. With remarkable offerings such as dual lens, vari-focal lens, 4K resolution, and AI features, this technology offers a wide-range of products and solutions that can effectively solve the arduous monitoring pain points of end-users and provide clear and vivid images of the monitored scene 24/7. (Photo: Business Wire)
Full-color + TiOC: effective deterrent against intruders
The Dahua TiOC (three-in-one camera) integrates Smart Dual Illuminators, Active Deterrence, and AI to offer a pro-active monitoring solution that can effectively warn off intruders. The combination of Dahua’s industry-leading full-color technology with powerful AI functions and real-time Active Deterrence warnings makes it suitable for places that require 24/7 security, such as villas, shops, warehouses, etc., helping to reduce false alarm rates, improve target search efficiency, generally optimize system operation, and reduce costs.
Full-color + Panoramic: the whole scene in vivid color
The Dahua Full-color Dual Lens 180° Panoramic PTZ & IPC are equipped with dual sensors that deliver a 180-degree field of view. It adopts the Dahua pixel-level seamless fusion algorithm to splice images into horizontal 180° monitoring scene, providing users with brilliant full-color and panoramic images. Featuring wide-area coverage, it is an excellent alternative to daunting installation of multiple cameras just to cover a large scene. Thanks to Full-color Technology, the intelligent panoramic camera can provide clear color images even at night, which is essential for 24/7 continuous monitoring in large application scenarios such as squares, hallways, and parking lots.
Full-color + ZOOM: vari-focal zoom in with vivid color
The Dahua Full-color Vari-focal Camera boasts approx. 5x optical zoom capability and auto-focus function. These cameras provide clear monitoring scene details even after zooming in, capture vivid color images in dark environments, and also allow users to directly adjust the camera’s focus according to the actual scene, which is convenient and time-saving.
Full-color + 4K: Realistic 4K UHD image quality
The Dahua Full-color 4K Camera delivers enhanced color images and video footages 24/7. It adopts 1/1.2” image sensor (currently Dahua's best low-light IPC sensor) that provides 110% pixel size increase compared to common 8MP sensor. Combined with a F1.0 large aperture, more available light can be captured to provide clear and vivid images, which is conductive to accurate video analysis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221121005376/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom